Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy

Biogen PE Ratio 2006-2018 | BIIB

Current and historical p/e ratio for Biogen (BIIB) from 2006 to 2018. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Biogen PE ratio as of March 20, 2019 is 12.34.
Biogen PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2019-03-20 320.59 14.84
2018-12-31 300.92 $21.60 13.93
2018-09-30 353.31 $15.47 22.84
2018-06-30 290.24 $14.11 20.57
2018-03-31 273.82 $14.00 19.56
2017-12-31 318.57 $11.92 26.73
2017-09-30 313.12 $16.31 19.20
2017-06-30 271.36 $15.23 17.82
2017-03-31 273.42 $15.95 17.14
2016-12-31 261.39 $16.92 15.45
2016-09-30 288.53 $17.70 16.30
2016-06-30 222.89 $17.14 13.00
2016-03-31 239.95 $16.28 14.74
2015-12-31 282.37 $15.34 18.41
2015-09-30 268.35 $15.31 17.53
2015-06-30 372.33 $14.78 25.19
2015-03-31 389.19 $13.86 28.08
2014-12-31 312.88 $12.39 25.25
2014-09-30 304.92 $10.57 28.85
2014-06-30 290.63 $9.00 32.29
2014-03-31 281.93 $8.05 35.02
2013-12-31 257.69 $7.82 32.95
2013-09-30 221.92 $7.13 31.12
2013-06-30 198.36 $6.75 29.39
2013-03-31 177.54 $6.30 28.18
2012-12-31 134.91 $5.76 23.42
2012-09-30 137.53 $5.75 23.92
2012-06-30 133.08 $5.51 24.15
2012-03-31 116.14 $5.08 22.86
2011-12-31 101.44 $5.03 20.17
2011-09-30 85.86 $4.80 17.89
2011-06-30 98.55 $4.42 22.30
2011-03-31 67.72 $4.36 15.53
2010-12-31 61.80 $3.96 15.61
2010-09-30 51.73 $4.03 12.84
2010-06-30 43.74 $3.93 11.13
2010-03-31 52.90 $3.30 16.03
2009-12-31 49.31 $3.34 14.76
2009-09-30 46.57 $2.98 15.63
2009-06-30 41.62 $2.73 15.24
2009-03-31 48.32 $2.94 16.43
2008-12-31 43.90 $2.64 16.63
2008-09-30 46.35 $2.61 17.76
2008-06-30 51.52 $2.32 22.21
2008-03-31 56.86 $2.16 26.33
2007-12-31 52.47 $2.00 26.23
2007-09-30 61.14 $1.65 37.05
2007-06-30 49.31 $1.69 29.18
2007-03-31 40.91 $0.65 62.93
2006-12-31 45.34 $0.63 71.97
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $63.686B $13.453B
Biogen is a leading biopharmaceutical company engaged in the research, development and marketing of targeted therapies for the treatment of cancer, autoimmune and inflammatory diseases. The company owns industry leading brands for the treatment of multiple sclerosis, next-generation treatments for hemophilia, and a deep clinical pipeline ranging from Alzheimer's disease, lupus nephritis to neuropathic pain.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $119.160B 13.29
Gilead Sciences (GILD) United States $83.533B 10.63
Celgene (CELG) United States $62.559B 11.57
Vertex Pharmaceuticals (VRTX) United States $46.468B 62.25
Illumina (ILMN) United States $45.673B 54.32
Regeneron Pharmaceuticals (REGN) United States $44.474B 20.66
Alexion Pharmaceuticals (ALXN) United States $29.708B 18.41
Incyte (INCY) United States $18.338B 171.34
BioMarin Pharmaceutical (BMRN) United States $16.310B 0.00
Seattle Genetics (SGEN) United States $11.698B 0.00
Exact Sciences (EXAS) United States $11.463B 0.00
Alnylam Pharmaceuticals (ALNY) United States $9.418B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.298B 53.05
Sarepta Therapeutics (SRPT) United States $9.016B 0.00
QIAGEN (QGEN) Netherlands $9.005B 29.80
Bluebird Bio (BLUE) United States $8.578B 0.00
BeiGene (BGNE) Cayman Islands $8.113B 0.00
Guardant Health (GH) United States $7.823B 0.00
Bio-Techne Corp (TECH) United States $7.518B 50.65
Exelixis (EXEL) United States $7.299B 17.01
Moderna (MRNA) United States $6.695B 0.00
Amarin (AMRN) Ireland $6.090B 0.00
Alkermes (ALKS) Ireland $5.463B 0.00
Array BioPharma (ARRY) United States $5.292B 0.00
Ascendis Pharma (ASND) Denmark $5.248B 0.00
Galapagos (GLPG) Belgium $5.178B 0.00
Horizon Pharma Public (HZNP) Ireland $4.785B 15.41
Spark Therapeutics (ONCE) United States $4.315B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.245B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.873B 0.00
Blueprint Medicines (BPMC) United States $3.704B 0.00
Immunomedics (IMMU) United States $3.580B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.509B 0.00
China Biologic Products (CBPO) China $3.469B 21.50
Intercept Pharmaceuticals (ICPT) United States $3.325B 0.00
Allogene Therapeutics (ALLO) United States $3.195B 0.00
Amicus Therapeutics (FOLD) United States $3.011B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $2.958B 0.00
Global Blood Therapeutics (GBT) United States $2.927B 0.00
Reata Pharmaceuticals (RETA) United States $2.767B 0.00
Genomic Health (GHDX) United States $2.752B 70.35
Akcea Therapeutics (AKCA) United States $2.634B 0.00
Repligen (RGEN) United States $2.608B 80.23
Mirati Therapeutics (MRTX) United States $2.581B 0.00
Ligand Pharmaceuticals (LGND) United States $2.536B 18.93
Emergent Biosolutions (EBS) United States $2.515B 20.99
UniQure (QURE) Netherlands $2.501B 0.00
Myriad Genetics (MYGN) United States $2.447B 24.92
Halozyme Therapeutics (HALO) United States $2.428B 0.00
Acceleron Pharma (XLRN) United States $2.392B 0.00
Arena Pharmaceuticals (ARNA) United States $2.271B 0.00
Insmed (INSM) United States $2.246B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $2.215B 0.00
MyoKardia (MYOK) United States $2.191B 0.00
REGENXBIO (RGNX) United States $2.133B 22.27
Denali Therapeutics (DNLI) United States $2.116B 0.00
AnaptysBio (ANAB) United States $2.013B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.996B 0.00
Medicines (MDCO) United States $1.960B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $1.947B 0.00
NeoGenomics (NEO) United States $1.855B 150.92
Atara Biotherapeutics (ATRA) United States $1.814B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.747B 0.00
Allakos (ALLK) United States $1.690B 0.00
Audentes Therapeutics (BOLD) United States $1.644B 0.00
Myovant Sciences (MYOV) United Kingdom $1.627B 0.00
WAVE Life Sciences (WVE) Singapore $1.575B 0.00
Puma Biotechnology (PBYI) United States $1.545B 0.00
GOSSAMER BIO (GOSS) United States $1.492B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.436B 0.00
Innoviva (INVA) United States $1.432B 3.94
Orchard Therapeutics Sponsored ADR (ORTX) United Kingdom $1.429B 0.00
Clovis Oncology (CLVS) United States $1.389B 0.00
Aimmune Therapeutics (AIMT) United States $1.348B 0.00
ALECTOR INC (ALEC) United States $1.317B 0.00
Cambrex (CBM) United States $1.313B 14.13
Rubius Therapeutics (RUBY) United States $1.282B 0.00
Lion Biotechnologies (IOVA) United States $1.260B 0.00
Apellis Pharmaceuticals (APLS) United States $1.252B 0.00
Editas Medicine (EDIT) United States $1.184B 0.00
Fate Therapeutics (FATE) United States $1.171B 0.00
RA PHARMCTL INC (RARX) United States $1.143B 0.00
Codexis (CDXS) United States $1.132B 0.00
InflaRx (IFRX) Germany $1.102B 0.00
Epizyme (EPZM) United States $1.096B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.045B 0.00
Coherus BioSciences (CHRS) United States $1.028B 0.00
Retrophin (RTRX) United States $1.003B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.002B 0.00
Sangamo Therapeutics (SGMO) United States $0.996B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.982B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.977B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.966B 39.04
Deciphera Pharmaceuticals (DCPH) United States $0.950B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.944B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.910B 0.00
Principia Biopharma (PRNB) United States $0.885B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.829B 0.00
Vericel (VCEL) United States $0.823B 0.00
Athenex (ATNX) United States $0.808B 0.00
Cellectis (CLLS) France $0.805B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.804B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.803B 0.00
Cara Therapeutics (CARA) United States $0.772B 0.00
Intellia Therapeutics (NTLA) United States $0.763B 0.00
Eidos Therapeutics (EIDX) United States $0.759B 0.00
ANI Pharmaceuticals (ANIP) United States $0.750B 13.73
Revance Therapeutics (RVNC) United States $0.719B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United Kingdom $0.711B 0.00
Intra-Cellular Therapies (ITCI) United States $0.699B 0.00
Synthorx (THOR) United States $0.685B 0.00
Acorda Therapeutics (ACOR) United States $0.684B 8.86
ZIOPHARM Oncology Inc (ZIOP) United States $0.659B 0.00
Osiris Therapeutics (OSIR) United States $0.657B 0.00
Heska (HSKA) United States $0.636B 57.09
Viking Therapeutics (VKTX) United States $0.621B 0.00
Twist Bioscience (TWST) United States $0.613B 0.00
Magenta Therapeutics (MGTA) United States $0.612B 0.00
Kura Oncology (KURA) United States $0.604B 0.00
G1 THERAPEUTICS (GTHX) United States $0.598B 0.00
ObsEva SA (OBSV) Switzerland $0.591B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.583B 0.00
MeiraGTx Holdings (MGTX) United States $0.561B 0.00
Prothena (PRTA) Ireland $0.560B 0.00
Arvinas (ARVN) United States $0.552B 0.00
UROGEN PHARMA (URGN) Israel $0.523B 0.00
Arcus Biosciences (RCUS) United States $0.515B 0.00
Dynavax Technologies (DVAX) United States $0.511B 0.00
DBV Technologies (DBVT) France $0.503B 0.00
Scholar Rock Holding (SRRK) United States $0.501B 0.00
Zealand Pharma (ZEAL) Denmark $0.496B 5.47
NuCana Sponsored ADR (NCNA) United Kingdom $0.494B 0.00
Mesoblast (MESO) Australia $0.492B 0.00
CytomX Therapeutics (CTMX) United States $0.489B 0.00
Zymeworks (ZYME) Canada $0.488B 0.00
Senesco Technologies (ELOX) United States $0.473B 0.00
PDL BioPharma (PDLI) United States $0.471B 10.51
Cytokineticsorporated (CYTK) United States $0.470B 0.00
Sorrento Therapeutics (SRNE) United States $0.470B 0.00
Five Prime Therapeutics (FPRX) United States $0.459B 0.00
AVROBIO (AVRO) United States $0.446B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.434B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.433B 0.00
Axsome Therapeutics (AXSM) United States $0.431B 0.00
Anika Therapeutics (ANIK) United States $0.428B 16.21
Stemline Therapeutics (STML) United States $0.425B 0.00
Replimune (REPL) United States $0.424B 0.00
MannKind (MNKD) United States $0.422B 0.00
Agenus (AGEN) United States $0.401B 0.00
BeyondSpring (BYSI) United States $0.386B 0.00
XBiotech (XBIT) United States $0.382B 0.00
STEALTH BIOTHER (MITO) United States $0.381B 0.00
UNITY Biotechnology (UBX) $0.381B 0.00
Abeona Therapeutics (ABEO) United States $0.381B 0.00
Solid Biosciences (SLDB) United States $0.371B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
Kadmon Holdings (KDMN) United States $0.369B 0.00
Kezar Life Sciences (KZR) United States $0.367B 0.00
Albireo Pharma (ALBO) United States $0.366B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.363B 0.00
Adverum Biotechnologies (ADVM) United States $0.360B 0.00
MediciNova (MNOV) United States $0.358B 0.00
Inovio Pharmaceuticals (INO) United States $0.351B 0.00
BioDelivery Sciences (BDSI) United States $0.351B 0.00
Gritstone Oncology (GRTS) United States $0.346B 0.00
Kindred Biosciences (KIN) United States $0.340B 0.00
OSMOTICA PHARM (OSMT) United States $0.337B 0.00
Urovant Sciences (UROV) United States $0.334B 0.00
Cellular Biomedicine (CBMG) United States $0.326B 0.00
Krystal Biotech (KRYS) United States $0.320B 0.00
Geron (GERN) United States $0.317B 0.00
Aduro Biotech (ADRO) United States $0.311B 0.00
Protagonist Therapeutics (PTGX) United States $0.304B 0.00
Strongbridge Biopharma (SBBP) United States $0.303B 0.00
AC Immune SA (ACIU) Switzerland $0.299B 0.00
Constellation Pharmaceuticals (CNST) United States $0.294B 0.00
Syros Pharmaceuticals (SYRS) United States $0.293B 0.00
Kala Pharmaceuticals (KALA) United States $0.288B 0.00
Merus (MRUS) Netherlands $0.285B 0.00
Enochian BioSciences (ENOB) United States $0.278B 0.00
Gamida Cell (GMDA) Israel $0.278B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.277B 0.00
Seres Therapeutics (MCRB) United States $0.273B 0.00
Evelo Biosciences (EVLO) United States $0.268B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.260B 0.00
Sutro Biopharma (STRO) United States $0.260B 0.00
Kodiak Sciences (KOD) United States $0.259B 0.00
Verastem (VSTM) United States $0.252B 0.00
TOCAGEN INC (TOCA) United States $0.247B 0.00
Novavax (NVAX) United States $0.244B 0.00
Cerecor (CERC) United States $0.243B 0.00
Avid Bioservices (CDMO) United States $0.243B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.242B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.238B 0.00
Kamada (KMDA) Israel $0.237B 10.70
Liquidia Technologies (LQDA) United States $0.237B 0.00
Mersana Therapeutics (MRSN) United States $0.237B 0.00
BioTime (BTX) United States $0.235B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.234B 0.00
Spero Therapeutics (SPRO) United States $0.228B 0.00
Athersys (ATHX) United States $0.228B 0.00
Intec Pharma (NTEC) Israel $0.225B 0.00
LogicBio Therapeutics (LOGC) United States $0.224B 0.00
Celyad SA (CYAD) Belgium $0.223B 0.00
ChromaDex (CDXC) United States $0.221B 0.00
Axovant Sciences (AXGT) United Kingdom $0.218B 0.00
Proteostasis Therapeutics (PTI) United States $0.213B 0.00
Arbutus Biopharma (ABUS) Canada $0.209B 0.00
Celcuity (CELC) United States $0.206B 0.00
Palatin Technologies (PTN) United States $0.203B 100.00
Paratek Pharmaceuticals (PRTK) United States $0.202B 0.00
ResTORbio (TORC) United States $0.196B 0.00
VBI Vaccines (VBIV) United States $0.195B 0.00
Synlogic (SYBX) United States $0.193B 0.00
Menlo Therapeutics (MNLO) United States $0.192B 0.00
Compugen (CGEN) Israel $0.190B 0.00
CorMedix Inc (CRMD) United States $0.188B 0.00
Cue Biopharma (CUE) United States $0.187B 0.00
ADMA Biologics Inc (ADMA) United States $0.184B 0.00
OvaScience (MLND) United States $0.182B 0.00
Trevena (TRVN) United States $0.174B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.172B 0.00
Pfenex (PFNX) United States $0.161B 0.00
BioXcel Therapeutics (BTAI) United States $0.161B 0.00
Chiasma (CHMA) United States $0.160B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.158B 0.00
Allena Pharmaceuticals (ALNA) United States $0.158B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.152B 0.00
PHASEBIO PHARMA (PHAS) United States $0.152B 0.00
Anavex Life Sciences (AVXL) United States $0.140B 0.00
Unum Therapeutics (UMRX) United States $0.139B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.139B 0.00
Aptinyx (APTX) United States $0.137B 0.00
Cohbar (CWBR) United States $0.137B 0.00
Eton Pharmaceuticals (ETON) United States $0.133B 0.00
Organovo Holdings (ONVO) United States $0.131B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.128B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.128B 0.00
Equillium (EQ) United States $0.128B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.128B 0.00
XOMA (XOMA) United States $0.126B 0.00
Enzo Biochem (ENZ) United States $0.123B 0.00
VolitionRX (VNRX) Singapore $0.120B 0.00
Catalyst Biosciences (CBIO) United States $0.116B 0.00
Pluristem Therapeutics (PSTI) Israel $0.114B 0.00
Fortress Biotech (FBIO) United States $0.113B 0.00
Mustang Bio (MBIO) United States $0.108B 0.00
Checkpoint Therapeutics (CKPT) United States $0.106B 0.00
NantKwest (NK) United States $0.105B 0.00
Signal Genetics (MGEN) United States $0.103B 0.00
Neothetics (EVFM) United States $0.102B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.096B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.095B 0.00
Cel-Sci (CVM) United States $0.092B 0.00
VTv Therapeutics (VTVT) United States $0.090B 0.00
ARAVIVE, INC (ARAV) United States $0.087B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.086B 0.00
Aptose Biosciences (APTO) Canada $0.085B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.085B 0.00
Idera Pharmaceuticals (IDRA) United States $0.084B 0.00
Cocrystal Pharma (COCP) United States $0.084B 93.33
Oncobiologics (OTLK) United States $0.084B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.083B 0.00
Provention Bio (PRVB) United States $0.081B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.080B 0.00
NewLink Genetics (NLNK) United States $0.080B 0.00
Alimera Sciences (ALIM) United States $0.079B 0.00
Applied Genetic Technologies (AGTC) United States $0.078B 0.00
INMUNE BIO INC (INMB) United States $0.077B 0.00
Orgenesis (ORGS) United States $0.077B 0.00
OVID THERAPEUTC (OVID) United States $0.076B 0.00
SESEN BIO, INC (SESN) United States $0.076B 0.00
Protalix BioTherapeutics (PLX) Israel $0.074B 0.00
Cidara Therapeutics (CDTX) United States $0.071B 0.00
AEterna Zentaris (AEZS) United States $0.069B 13.19
Akari Therapeutics (AKTX) United Kingdom $0.069B 0.00
Proteon Therapeutics (PRTO) United States $0.066B 0.00
Eyenovia (EYEN) United States $0.065B 0.00
Prima BioMed (IMMP) Australia $0.064B 0.00
Tiziana Life Sciences Sponsored ADR (TLSA) United Kingdom $0.064B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.064B 0.00
Ophthotech (OPHT) United States $0.063B 0.00
Vascular Biogenics (VBLT) Israel $0.063B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.059B 0.00
ScPharmaceuticals (SCPH) United States $0.059B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.059B 0.00
Celldex Therapeutics (CLDX) United States $0.058B 0.00
Zosano Pharma (ZSAN) United States $0.058B 0.00
Alcobra (ARCT) United States $0.058B 0.00
VistaGen Therapeutics (VTGN) United States $0.057B 0.00
Selecta Biosciences (SELB) United States $0.057B 0.00
Arsanis (XFOR) United States $0.054B 0.00
ANCHIANO THERAP (ANCN) Israel $0.052B 0.00
Clearside Biomedical (CLSD) United States $0.051B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.051B 0.00
Evogene (EVGN) Israel $0.049B 0.00
VIVUS (VVUS) United States $0.049B 0.00
Bellerophon Therapeutics (BLPH) United States $0.049B 0.00
Curis (CRIS) United States $0.048B 0.00
Entera Bio (ENTX) Israel $0.047B 0.00
Vaccinex (VCNX) United States $0.047B 0.00
Bionano Genomics (BNGO) United States $0.047B 0.00
TRACON Pharmaceuticals (TCON) United States $0.046B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.045B 0.00
Leap Therapeutics (LPTX) United States $0.045B 0.00
Celsion (CLSN) United States $0.040B 0.00
DiaMedica Therapeutics (DMAC) United States $0.039B 0.00
Caladrius Biosciences (CLBS) United States $0.039B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.037B 0.00
AZURRX BIOPHARM (AZRX) United States $0.036B 0.00
Moleculin Biotech (MBRX) United States $0.036B 0.00
OncoSec Medical (ONCS) United States $0.036B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.035B 0.00
AquaBounty Technologies (AQB) United States $0.034B 0.00
Sophiris Bio (SPHS) United States $0.034B 0.00
Oncolytics Biotech (ONCY) Canada $0.033B 0.00
Aileron Therapeutics (ALRN) United States $0.032B 0.00
Advaxis (ADXS) United States $0.032B 0.00
BioPharmX (BPMX) United States $0.031B 0.00
GTx (GTXI) United States $0.031B 0.00
GENPREX INC (GNPX) United States $0.030B 0.00
Galena Biopharma (SLS) United States $0.029B 0.00
Adial Pharmaceuticals (ADIL) United States $0.029B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.027B 0.00
Oragenics (OGEN) United States $0.026B 0.00
IMMURON LTD (IMRN) Australia $0.026B 0.00
CytRx (CYTR) United States $0.026B 0.00
Aytu Bioscience (AYTU) United States $0.025B 0.00
Vical (VICL) United States $0.025B 0.00
Motif Bio Plc (MTFB) United States $0.024B 0.00
Novelion Therapeutics (NVLN) Canada $0.024B 0.00
Titan Pharmaceuticals (TTNP) United States $0.023B 0.00
Benitec Biopharma (BNTC) Australia $0.022B 0.00
Dare Bioscience (DARE) United States $0.021B 0.00
Aptevo Therapeutics (APVO) United States $0.019B 0.00
Fibrocell Science Inc (FCSC) United States $0.019B 0.00
Cleveland BioLabs (CBLI) United States $0.018B 0.00
Novogen (KZIA) Australia $0.018B 0.00
IBio (IBIO) United States $0.017B 0.00
Gemphire Therapeutics (GEMP) United States $0.017B 0.00
Prana Biotechnology (PRAN) Australia $0.017B 0.00
Soligenix (SNGX) United States $0.017B 0.00
Apricus Biosciences (SEEL) United States $0.016B 0.00
RestorGenex (DFFN) United States $0.016B 0.00
TrovaGene (TROV) United States $0.016B 0.00
ATyr Pharma (LIFE) United States $0.015B 0.00
Therapix Biosciences (TRPX) Israel $0.015B 7.67
Genetic Technologies (GENE) Australia $0.015B 0.00
Pulmatrix (PULM) United States $0.014B 0.00
Alliqua BioMedical (ALQA) United States $0.013B 0.00
Synthetic Biologics (SYN) United States $0.012B 0.00
MYOS RENS Technology (MYOS) United States $0.011B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.011B 0.00
Neuralstem (CUR) United States $0.011B 0.00
AmpliPhi Biosciences (APHB) United States $0.010B 0.00
Histogenics (HSGX) United States $0.009B 0.00
Vital Therapies (VTL) United States $0.009B 0.00
Hemispherx BioPharma (HEB) United States $0.008B 0.00
ARCA Biopharma (ABIO) United States $0.007B 0.00
Flex Pharma (FLKS) United States $0.007B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Cellect Biotechnology (APOP) Israel $0.006B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.005B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.004B 0.00
Tenax Therapeutics (TENX) United States $0.003B 0.00
HOTH THERAPEUTC (HOTH) United States $0.000B 0.00